SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-108339
Filing Date
2021-04-07
Accepted
2021-04-07 09:32:59
Documents
3
Period of Report
2021-04-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d112260d8k.htm 8-K 19548
2 EX-99.1 d112260dex991.htm EX-99.1 10198
3 GRAPHIC g112260allena.jpg GRAPHIC 7672
  Complete submission text file 0001193125-21-108339.txt   41726
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 21810934
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences